ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Berlin, BE, DEU:

Atezolizumab Trial in Endometrial Cancer - AtTEnd

Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...

Active, not recruiting
Endometrial Cancer
Drug: Placebos
Drug: Atezolizumab

Phase 3

Mario Negri Institute for Pharmacological Research

Berlin, Berlin, Germany and 92 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Berlin, Germany and 65 other locations

for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...

Active, not recruiting
Endometrial Cancer
Drug: Matching placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Berlin, Germany and 77 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Doxorubicin
Drug: Paclitaxel

Phase 3

Eisai
Eisai

Berlin, Germany and 168 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Cisplatin
Drug: Leucovorin LV

Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 92 other locations

This study will test the safety of a drug called SGN-B7H4V in participants with solid tumors. It will also study the side effects of this dr...

Enrolling
Ovarian Neoplasms
Hormone Receptor Positive Breast Neoplasms
Drug: SGN-B7H4V

Phase 1

Seagen
Seagen

Berlin, Other, Germany and 18 other locations

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...

Enrolling
Endometrial Cancer
Drug: Matching Placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Berlin, Germany and 165 other locations

Locations recently updated

This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial ...

Enrolling
Recurrent or Metastatic Solid Tumors
Drug: Ifinatamab deruxtecan

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Berlin, Germany and 105 other locations

cells (CAR-T) with or without CLDN6 ribonucleic acid lipoplexes (RNA-LPX) in patients with CLDN6-positive relapsed or refractory advanced solid tumors...

Enrolling
Solid Tumor
Biological: CLDN6 CAR-T
Biological: CLDN6 uRNA-LPX/CLDN6 modRNA-LPX

Phase 1

BioNTech
BioNTech

Berlin, Germany and 11 other locations

progression-free survival in participants with cervical cancer....

Active, not recruiting
Ovarian Neoplasms
Uterine Cervical Neoplasms
Drug: Docetaxel
Drug: Gemcitabine

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Berlin, Germany and 72 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems